Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 3Other hematologic neoplasm 2Lymphoid 1Gynecologic 1Gastrointestinal 1CNS 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myocarditis 1Muscle Weakness 1Hematologic Neoplasms 1

Interventions

venetoclax 73Specimen Handling 66Cyclophosphamide 58Cytarabine 50Biopsy 49fludarabine 42Azacitidine 37Rituximab 28fludarabine phosphate 21blinatumomab 20Methotrexate 20Magnetic Resonance Spectroscopy 20Daunorubicin 20Vincristine 19Prednisone 18ibrutinib 16Injections 16Dexamethasone 16decitabine and cedazuridine drug combination 15Whole-Body Irradiation 15Tacrolimus 14Melphalan 14Doxorubicin 14Busulfan 14obinutuzumab 13acalabrutinib 13Mycophenolic Acid 13Granulocyte Colony-Stimulating Factor 13merphos 12Mercaptopurine 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Positron-Emission Tomography × Other hematologic neoplasm × 30 days × Clear all
NCT06819475 2026-05-18

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

St. Jude Children's Research Hospital

Phase NA Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Neoplasms, Muscle Weakness, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06566209 2026-05-08

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

Mayo Clinic

Terminated
2 enrolled
Other hematologic neoplasm

Myocarditis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡